胰腺浸润性导管内乳头状黏液性肿瘤:薄层增强MDCT所见壁结节与浸润成分的关系
回顾性纳入28例手术证实的浸润性IPMN,两名放射科医师独立评估1mm薄层三期增强MDCT上的壁结节、浸润成分及两者连续性。壁结节见于12例(42.9%),病理证实壁结节与浸润成分连续者仅5例(41.7%);浸润成分更多源自无壁结节表现的低矮乳头状上皮(23/28,82.1%)。
要点
- 浸润成分在胰腺实质期呈低密度区,检出率分别为85.7%和82.1%。
- 壁结节与浸润成分的病理连续仅见于5/12例有壁结节患者。
- 无强化壁结节时仍需注意浸润成分存在。
核心结论
- 浸润成分更多源自CE-MDCT上无壁结节表现的低矮乳头状上皮,而非壁结节。
- 即使缺乏强化壁结节,也应注意浸润成分的存在。
研究设计与样本
- 回顾性研究,纳入28例手术证实的浸润性IPMN患者。
- 采用1mm层厚、无重叠的三期增强MDCT,两名放射科医师独立评估壁结节、浸润成分及两者连续性,采用5分置信评分(1-3分为阴性,4-5分为阳性)。
- 以病理 findings 为参考标准,用Kappa统计量评价观察者间一致性。
关键影像表现/征象
- 浸润成分在胰腺实质期表现为低密度区,医师1检出率85.7%,医师2检出率82.1%。
- 由肿瘤细胞构成的壁结节见于12/28例(42.9%),两名医师间无分歧。
- 12例有壁结节患者中,病理证实壁结节与浸润成分连续者5例(41.7%),且CE-MDCT上均检出该连续性。
诊断标准与关键数值
- 壁结节、浸润成分及两者连续性的CE-MDCT评估采用5分置信评分:1-3分为阴性,4和5分为阳性。
- 观察者间一致性为良好或优秀。
临床应用与阅片要点
- 阅片时需在胰腺实质期关注低密度浸润成分,即使未见强化壁结节也不可忽视。
- 壁结节与浸润成分的连续性在CE-MDCT上可被检出,但仅见于部分有壁结节患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To elucidate the relationships between mural nodules (MNs) and invasive components in patients with invasive intraductal papillary mucinous neoplasm (IPMN) on the basis of thin-section contrast-enhanced multidetector CT (CE-MDCT) and pathologic findings.
METHODS: This retrospective study included 28 patients with surgically confirmed invasive IPMN. Two radiologists independently evaluated the thin-section (1-mm section thickness, no overlap) triple-phase CE-MDCT images for MNs, invasive components, and the continuity between them using a five-point scale (confidence scores of 1-3 as negative, 4 and 5 as positive). Kappa statistic was used to evaluate interobserver agreement. The CE-MDCT findings were correlated with pathologic findings.
RESULTS: Interobserver agreement was good or excellent. MNs consisting of tumor cells were recognized in 12 (42.9%) of 28 patients with no discrepancy between the two radiologists. Invasive components were detected in 85.7% and 82.1% in the pancreatic parenchymal phase for radiologist 1 and 2, respectively, and recognized as hypoattenuating areas. Pathologic continuities between MNs and invasive components were confirmed in five (41.7%) of 12 patients with MNs and these were detected on CE-MDCT. When combined seven patients without continuities between MNs and invasive components and 16 patients without MNs, the invasive components pathologically derived from non-nodular low-height papillary epithelium in 23 (82.1%) of 28 patients.
CONCLUSIONS: The invasive components derived more often from low-height papillary epithelium without MN appearance on CE-MDCT than from MN. Careful attention should be paid to the existence of an invasive component even in the absence of an enhancing MN.
引用
- Kamei N, Yamada Y, Hijiya N, et al. Invasive intraductal papillary mucinous neoplasms of the pancreas: relationships between mural nodules detected on thin-section contrast-enhanced MDCT and invasive components. Abdom Radiol (NY). 2019. PMID: 31168723. doi:10.1007/s00261-019-02084-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。